Michael Klichinsky
Fondateur chez CARISMA THERAPEUTICS, INC.
Fortune : 794 329 $ au 30/04/2024
Postes actifs de Michael Klichinsky
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/04/2022 | - |
| Fondateur | 01/01/2016 | - | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Directeur Technique/Scientifique/R&D | 01/04/2022 | - |
| Fondateur | 01/01/2016 | - | |
| Corporate Officer/Principal | 01/10/2018 | 01/04/2022 |
Historique de carrière de Michael Klichinsky
Formation de Michael Klichinsky
| University of Pennsylvania | Doctorate Degree |
| University of the Sciences in Philadelphia | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Doctorate Degree | 2 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Bourse
- Insiders
- Michael Klichinsky
- Expérience